Recent advances in understanding and managing chordomas

Carlos A. Bagley, Carl Youssef, Salah Aoun, Jessica R. Moreno

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


Chordomas are rare primary bone tumors arising from embryonic remnants of the notochord. They are slow-growing, locally aggressive, and destructive and typically involve the axial skeleton. Genetic studies have identified several mutations implicated in the pathogenesis of these tumors. Treatment poses a challenge given their insidious progression, degree of local invasion at presentation, and high recurrence rate. They tend to respond poorly to conventional chemotherapy and radiation. This makes radical resection the mainstay of their treatment. Recent advances in targeted chemotherapy and focused particle beam radiation, however, have improved the management and prognosis of these tumors.

Original languageEnglish (US)
Article number2902
StatePublished - 2016


  • Chordoma
  • Chordomas
  • Focused particle beam radiation
  • Primary bone tumors
  • Primary bone tumours
  • Targeted chemotherapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Recent advances in understanding and managing chordomas'. Together they form a unique fingerprint.

Cite this